Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
certican tafla 0,75 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,75 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
certican tafla 0,5 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,5 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
certican tafla 0,25 mg
novartis healthcare a/s - everolimusum inn - tafla - 0,25 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rosuvastatin xiromed filmuhúðuð tafla 5 mg
medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 5 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rosuvastatin krka filmuhúðuð tafla 10 mg
krka sverige ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 10 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rosuvastatin krka filmuhúðuð tafla 20 mg
krka sverige ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 20 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rosuvastatin krka filmuhúðuð tafla 5 mg
krka sverige ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 5 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rosuvastatin xiromed filmuhúðuð tafla 40 mg
medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 40 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
warfarin teva tafla 3 mg
teva b.v.* - warfarinum natríum - tafla - 3 mg
Europäische Union -
Isländisch -
EMA (European Medicines Agency)
epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 og 5.